Posts

Showing posts with the label evfm

Evfm Stock News

Image
16 Zeilen News zur EVOFEM BIOSCIENCES AKTIE und aktueller Realtime-Aktienkurs GSK ViiVs. Macys Stock is Basing For a Breakout. 9szjzupxm39ehm Recently in News on March 29 2021 Evofem Biosciences Announces Closing of Public Offering of Common Stock. Evfm stock news . Get news for Nasdaq companies quoted on the stock market press releases financial disclosures and multimedia content for investment community individual investors and the general public. News is on the way evofem has to have something up their sleeve to pull off an offering they way they did. EVFM today announced the closing of its previously announced underwritten public offering of 17142857 shares of its common stock. With a year-over-year growth in debt of 4352436 Evofem Biosciences Incs debt growth rate surpasses 9986 of about US stocks. EVFM today announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi lactic acid citric acid potassium bitartrate will be presented at the 2021 Amer